Literature DB >> 25979466

Erythrocyte polyunsaturated fatty acid levels in young people at ultra-high risk for psychotic disorder and healthy adolescent controls.

Simon M Rice1, Miriam R Schäfer1, Claudia Klier2, Nilufar Mossaheb3, Nandita Vijayakumar4, Günter Paul Amminger5.   

Abstract

Erythrocyte polyunsaturated fatty acid (PUFA) levels from individuals at ultra-high risk (UHR) for psychosis (n = 80) were compared to existing data from healthy controls (n = 142). Results demonstrated PUFA deficits (α-linolenic acid, eicosapentanoic acid, all ω-6 PUFAs) for the UHR group. Findings provide a rationale for PUFA based interventions in emerging psychosis.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Polyunsaturated fatty acids; Psychosis; Ultra-high risk

Mesh：

Substances：

Year:  2015        PMID： 25979466     DOI： 10.1016/j.psychres.2015.04.036

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN： 0165-1781            Impact factor:   3.222


  8 in total

1.  First-episode bipolar disorder is associated with erythrocyte membrane docosahexaenoic acid deficits: Dissociation from clinical response to lithium or quetiapine.

Authors:  Robert K McNamara; Ronald Jandacek; Patrick Tso; Thomas J Blom; Jeffrey A Welge; Jeffrey R Strawn; Caleb M Adler; Melissa P DelBello; Stephen M Strakowski
Journal:  Psychiatry Res       Date:  2015-10-09       Impact factor: 3.222

2.  Altered serum fatty acid composition in geriatric depression.

Authors:  Ivo Marx; Panagiotis Alexopoulos; Gisela Irmisch; Savvas Topalidis; Zois Syrgiannis; Sabine C Herpertz; Stefan Cohrs
Journal:  J Neural Transm (Vienna)       Date:  2015-09-29       Impact factor: 3.575

3.  Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers.

Authors:  S R Clark; B T Baune; K O Schubert; S Lavoie; S Smesny; S M Rice; M R Schäfer; F Benninger; M Feucht; C M Klier; P D McGorry; G P Amminger
Journal:  Transl Psychiatry       Date:  2016-09-20       Impact factor: 6.222

4.  Relationship between Erythrocyte Fatty Acid Composition and Psychopathology in the Vienna Omega-3 Study.

Authors:  Sung-Wan Kim; Min Jhon; Jae-Min Kim; Stefan Smesny; Simon Rice; Michael Berk; Claudia M Klier; Patrick D McGorry; Miriam R Schäfer; G Paul Amminger
Journal:  PLoS One       Date:  2016-03-10       Impact factor: 3.240

5.  Identification of a plasma signature of psychotic disorder in children and adolescents from the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort.

Authors:  A O'Gorman; T Suvitaival; L Ahonen; M Cannon; S Zammit; G Lewis; H M Roche; I Mattila; T Hyotylainen; M Oresic; L Brennan; D R Cotter
Journal:  Transl Psychiatry       Date:  2017-09-26       Impact factor: 6.222

Review 6.  Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: possible mechanisms.

Authors:  Mei-Chi Hsu; Yung-Sheng Huang; Wen-Chen Ouyang
Journal:  Lipids Health Dis       Date:  2020-07-03       Impact factor: 3.876

7.  Relationship Between Polyunsaturated Fatty Acids and Psychopathology in the NEURAPRO Clinical Trial.

Authors:  Maximus Berger; Barnaby Nelson; Connie Markulev; Hok Pan Yuen; Miriam R Schäfer; Nilufar Mossaheb; Monika Schlögelhofer; Stefan Smesny; Ian B Hickie; Gregor E Berger; Eric Y H Chen; Lieuwe de Haan; Dorien H Nieman; Merete Nordentoft; Anita Riecher-Rössler; Swapna Verma; Andrew Thompson; Alison Ruth Yung; Patrick D McGorry; G Paul Amminger
Journal:  Front Psychiatry       Date:  2019-06-06       Impact factor: 4.157

8.  Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and Children.

Authors:  Francisco Madrid-Gambin; Melanie Föcking; Sophie Sabherwal; Meike Heurich; Jane A English; Aoife O'Gorman; Tommi Suvitaival; Linda Ahonen; Mary Cannon; Glyn Lewis; Ismo Mattila; Caitriona Scaife; Sean Madden; Tuulia Hyötyläinen; Matej Orešič; Stanley Zammit; Gerard Cagney; David R Cotter; Lorraine Brennan
Journal:  Biol Psychiatry       Date:  2019-01-30       Impact factor: 13.382
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.